I figured this may add a pinch of interesting info regarding the JnJ Vaccine issue
So, I was training a lady last nite who works for BioNTech and i've spoken to her many times during this past year (picked her Brain on Covid vaccine topics) . She has been in the field of vaccine research for decades. I asked her particularly about the JnJ situation.
She said that it was not a major surprise to her that the JnJ vaccine has a few issues related to blood cots. She mentioned that the JnJ Vaccine used the Adenovirus vector Techology (just like Astrazeneca) and that there was a indication in Phase 1 that this delivery method could increase odds of blood clots. She said Women on Birth Control are more prone to clots and that this appears to be exasperated by the adenorvirus delivery route and she speculated that JNJ will be resumed in a few weeks for use by Men who don't bear much clot risk and that they just needed more data for FDA to weigh Risk/Reward for other groups (women/ women not on birth control, etc). Anyway my talks with her are always interesting and wanted to share.